SCHEMBL1081706

SCHEMBL1081706

CC1CCC(C(=O)O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182183 1.00
SCHEMBL1467724 1.00
SCHEMBL6573684 1.00
SCHEMBL3830467 1.00
SCHEMBL2033291 1.00
SCHEMBL26611997 1.00
Hydrochloric Acid SCHEMBL7701941 0.98 CYP2C19 (0.46)
Hydrochloric Acid SCHEMBL7701945 0.98 CYP2C19 (0.46)
Hydrochloric Acid SCHEMBL21874191 0.98 CYP2C19 (0.46)
Hydrochloric Acid SCHEMBL14893315 0.98 CYP2C19 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140155371-A1 MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE BASF SE (DE) 2014-06-05 US claimed
WO-2013014604-A1 MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE BASF SE (DE) 2013-01-31 WO claimed
WO-2011085393-A1 STABLE INSULIN FORMULATIONS AND METHODS OF MAKING AND USING THEREOF GENECOPOEIA, INC. (US) 2011-07-14 WO claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
WO-2025081231-A1 INHIBITORS AND USES THEREFOR Infensa Bioscience Pty Ltd (AU) 2025-04-24 WO disclosed
US-20240344241-A1 PROTEINACEOUS MOLECULES AND USES THEREFOR THE UNIVERSITY OF TOKYO (JP) 2024-10-17 US disclosed
EP-4416282-A1 PROTEINACEOUS MOLECULES AND USES THEREFOR The University of Queensland (AU) 2024-08-21 EP disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
EP-4217070-A1 PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Scorpion Therapeutics, Inc. (US) 2023-08-02 EP disclosed
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN disclosed
WO-2023077188-A1 PROTEINACEOUS MOLECULES AND USES THEREFOR EPIAXIS THERAPEUTICS PTY LTD (AU) 2023-05-11 WO disclosed
WO-2023060319-A1 PROTEINACEOUS MOLECULES AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2023-04-20 WO disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US disclosed
EP-0787010-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-06 EP disclosed
WO-1996012499-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-05-02 WO disclosed
US-5114920-A BU-3292T antibiotics BRISTOL-MYERS SQUIBB CO. (US) 1992-05-19 US disclosed
US-4217238-A BASIC SALT, SCRUBBING EXXON RESEARCH & ENGINEERING CO. (US) 1980-08-12 US disclosed
US-4094957-A CARBON DIOXIDE EXXON RESEARCH & ENGINEERING CO. (US) 1978-06-13 US disclosed